Markets:

Overview

News

Currencies

International

Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

181.21 -1.73 (-0.95%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying ↗

July 06, 2022

Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.

Via Investor's Business Daily

What SVB Says On Axsome's Strategy Review On Sunosi For Sleeping Disorder ↗

June 29, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) held an investor event to review its strategy with Sunosi, which is indicated for excessive daytime sleepiness (EDS) in narcolepsy and obstructive sleep apnea...

Via Benzinga

Analyst Ratings for Axsome Therapeutics ↗

June 29, 2022

Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter:

Via Benzinga

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies ↗

June 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

EV Stocks TSLA, NIO, RIVN See Price Targets Slashed ↗

June 27, 2022

Electric vehicle (EV) stocks are in the news today after Mizuho analyst Vijay Rakesh weighed in on several companies in the space.

Via InvestorPlace

Where Axsome Therapeutics Stands With Analysts ↗

May 03, 2022

Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter:

Via Benzinga

As Expected, FDA Rejects Axsome Therapeutics' Migraine Candidate ↗

May 02, 2022

Via Benzinga

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗

June 28, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

Axsome Therapeutics Just Took Its Key Moving Averages — Here's Why ↗

June 27, 2022

The stock surged by double digits in early trading.

Via Investor's Business Daily

Recap: Axsome Therapeutics Q1 Earnings ↗

May 02, 2022

Axsome Therapeutics (NASDAQ:AXSM) reported its Q1 earnings results on Monday, May 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Axsome Poised To Receive FDA Rejection For Its Migraine Candidate, Shares Fall ↗

April 25, 2022

Via Benzinga

Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session ↗

June 27, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.

Via Benzinga

Axsome Therapeutics Rallies 40% On FDA Product Label Proposal, But Analyst Remains Skeptical ↗

June 27, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) shares rallied 40% on Monday morning after the company received some positive news from the U.S. Food and Drug Administration regarding its AXS-05 novel treatment...

Via Benzinga

Axsome Therapeutics (AXSM) Stock Soars on FDA Labeling Proposal ↗

June 27, 2022

Axsome Therapeutics (AXSM) stock is rising higher on Monday following an update from the FDA about product labeling for one of its drugs.

Via InvestorPlace

U.S. Markets Open Lower; Durable Goods Orders Rise 0.7% ↗

June 27, 2022

U.S. stocks traded lower this morning, with the Nasdaq Composite dropping over 100 points on Monday.

Via Benzinga

Why Axsome Therapeutics Stock Is Soaring Today ↗

June 27, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday after the company received proposed labeling from the U.S. Food and Drug Administration for its treatment of major depressive...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 27, 2022

Via Benzinga

6 Biotech Stocks to Buy Now Ahead of These June Catalysts ↗

June 03, 2022

These biotech stocks face some key make-or-break events in June that could have big implication for their futures.

Via InvestorPlace

Jazz Pharmaceuticals Completes U.S. Divestiture Of Sunosi To Axsome Therapeutics, What's Next? ↗

May 09, 2022

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has completed the divestiture of Sunosi (solriamfetol) in the U.S.

Via Benzinga

92 Biggest Movers From Friday ↗

May 09, 2022

Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...

Via Benzinga

FDA Issues Complete Response Letter (CRL) to Axsome Therapeutics for AXS-07 In Acute Migraine ↗

May 02, 2022

The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Axsome Therapeutics, Inc. (NASDAQ: AXSM) regarding its New Drug Application (NDA) for AXS-07 for the acute...

Via Benzinga

May 02, 2022

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...

Via Benzinga

A Preview Of Axsome Therapeutics's Earnings ↗

April 29, 2022

Axsome Therapeutics (NASDAQ:AXSM) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Axsome...

Via Benzinga

Axsome Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 26, 2022

Axsome Therapeutics (NASDAQ:AXSM) will host a conference call at 08:00 AM ET on May 2, 2022, to discuss Q1 2022 earnings results.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 25, 2022

Via Benzinga

Earnings Scheduled For May 2, 2022 ↗

May 02, 2022

Companies Reporting Before The Bell • New Gold (AMEX:NGD) is estimated to report quarterly earnings at $0.03 per share on revenue of $212.42 million.

Via Benzinga

60 Biggest Movers From Yesterday ↗

April 26, 2022

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two...

Via Benzinga

34 Stocks Moving In Monday's Mid-Day Session ↗

April 25, 2022

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen...

Via Benzinga

Why Is Axsome Therapeutics (AXSM) Stock Down Today? ↗

April 25, 2022

Axsome Therapeutics (AXSM) stock is falling hard on Monday following a report about an upcoming decision from the FDA this week.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Lower; Dow Tumbles Over 300 Points ↗

April 25, 2022

U.S. stocks opened lower this morning, with the Dow Jones dropping more than 300 points on Monday.

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

Headline News about Axsome Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today